Toll-like Receptors

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 33: Line 33:
 
 
 +
 +
==3D Structures of Toll-like Receptors==
 +
[[Toll-like Receptor 3D structures]]
</StructureSection>
</StructureSection>
Line 50: Line 53:
**[[1fyx]], [[1o77]] - hTLR2 TIR domain (mutant) <br />
**[[1fyx]], [[1o77]] - hTLR2 TIR domain (mutant) <br />
**[[2z80]] – hTLR2/VLRB.61<br />
**[[2z80]] – hTLR2/VLRB.61<br />
 +
**[[3a79]] – hTLR2/VLRB.61 + hTLR6/VLRB.61 + lipopeptide<br />
**[[3a7b]] - mTLR2/VLRB.61 – mouse<br />
**[[3a7b]] - mTLR2/VLRB.61 – mouse<br />
**[[3a7c]] - mTLR2/VLRB.61 + PE-DTPA<br />
**[[3a7c]] - mTLR2/VLRB.61 + PE-DTPA<br />
-
**[[3a79]] – hTLR2/VLRB.61 + hTLR6/VLRB.61 + lipopeptide<br />
 
**[[5d3i]] – mTLR2 + SSL3<br />
**[[5d3i]] – mTLR2 + SSL3<br />
Line 59: Line 62:
**[[1ziw]], [[2a0z]] – hTLR3 ligand-binding domain<br />
**[[1ziw]], [[2a0z]] – hTLR3 ligand-binding domain<br />
**[[5gs0]] – hTLR3 ectodomain + antibody<br />
**[[5gs0]] – hTLR3 ectodomain + antibody<br />
 +
**[[2mk9]], [[2mka]] – hTLR3 transmembrane domain - NMR <br />
**[[3cig]] – mTLR3 ectodomain<br />
**[[3cig]] – mTLR3 ectodomain<br />
**[[3ciy]] - mTLR3 ectodomain + RNA<br />
**[[3ciy]] - mTLR3 ectodomain + RNA<br />
-
**[[2mk9]], [[2mka]] – hTLR3 transmembrane domain - NMR <br />
 
*Toll-like receptor 4
*Toll-like receptor 4
Line 68: Line 71:
**[[3ul8]], [[3ul7]] – hTLR4/VLRB.61 (mutant)<br />
**[[3ul8]], [[3ul7]] – hTLR4/VLRB.61 (mutant)<br />
**[[5nam]], [[5nao]] – hTLR4 transmembrane domain - NMR<br />
**[[5nam]], [[5nao]] – hTLR4 transmembrane domain - NMR<br />
-
**[[2z64]], [[2z65]], [[5ijc]], [[5ijd]] – mTLR4 extracellular domain+ lymphocyte antigen 96<br />
 
**[[3fxi]], [[4g8a]] - hTLR4 extracellular domain + lymphocyte antigen 96<br />
**[[3fxi]], [[4g8a]] - hTLR4 extracellular domain + lymphocyte antigen 96<br />
**[[3ula]] - hTLR4/VLRB.61 + lymphocyte antigen 96<br />
**[[3ula]] - hTLR4/VLRB.61 + lymphocyte antigen 96<br />
 +
**[[2z64]], [[2z65]], [[5ijc]], [[5ijd]], [[3vq1]], [[3vq2]] – mTLR4 extracellular domain+ lymphocyte antigen 96<br />
-
*Toll-like receptor 5
+
*Toll-like receptor 5B
-
**[[5gy2]] – zTLR5B N-terminal + flagellin - zebrafish <br />
+
**[[5gy2]] – zfTLR5B N-terminal + flagellin - zebrafish <br />
-
**[[6bxa]] – zTLR5B N-terminal + VLR2 <br />
+
**[[6bxa]] – zfTLR5B N-terminal + VLR2 <br />
-
**[[6bxc]] – zTLR5B N-terminal + VLR9 <br />
+
**[[6bxc]] – zfTLR5B N-terminal + VLR9 <br />
 +
**[[3v44]] – zfTLR5B/VLRB.61 <br />
 +
**[[3v47]] – zfTLR5B/VLRB.61 + flagellin<br />
*Toll-like receptor 6
*Toll-like receptor 6

Revision as of 10:59, 27 February 2020

Glycosylated mouse toll-like receptor 3 dimer complex with double-stranded RNA 3ciy

Drag the structure with the mouse to rotate

Contents

3D Structures of Toll-like Receptors

Updated on 27-February-2020


References and Notes

  1. Gong J, Wei T, Zhang N, Jamitzky F, Heckl WM, Rossle SC, Stark RW. TollML: a database of toll-like receptor structural motifs. J Mol Model. 2010 Jul;16(7):1283-9. Epub 2010 Jan 19. PMID:20084417 doi:10.1007/s00894-009-0640-9
  2. Arancibia SA, Beltran CJ, Aguirre IM, Silva P, Peralta AL, Malinarich F, Hermoso MA. Toll-like receptors are key participants in innate immune responses. Biol Res. 2007;40(2):97-112. Epub 2007 Nov 21. PMID:18064347 doi:/S0716-97602007000200001
  3. Ganley-Leal LM, Liu X, Wetzler LM. Toll-like receptor 2-mediated human B cell differentiation. Clin Immunol. 2006 Sep;120(3):272-84. PMID:16766226 doi:http://dx.doi.org/10.1016/j.clim.2006.04.571
  4. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton MJ, Oikawa M, Qureshi N, Monks B, Finberg RW, Ingalls RR, Golenbock DT. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest. 2000 Feb;105(4):497-504. PMID:10683379 doi:http://dx.doi.org/10.1172/JCI8541
  5. Jarchum I, Liu M, Lipuma L, Pamer EG. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect Immun. 2011 Apr;79(4):1498-503. doi: 10.1128/IAI.01196-10. Epub 2011 Jan, 18. PMID:21245274 doi:http://dx.doi.org/10.1128/IAI.01196-10
  6. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol. 2001 Jul;13(7):933-40. PMID:11431423
  7. Lee AS, Ghoreishi M, Cheng WK, Chang TY, Zhang YQ, Dutz JP. Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse. Diabetologia. 2011 Jun;54(6):1407-16. doi: 10.1007/s00125-011-2083-y. Epub 2011, Feb 22. PMID:21340621 doi:http://dx.doi.org/10.1007/s00125-011-2083-y
  8. Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY, Li Y, Wang HY, Wang RF. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science. 2005 Aug 26;309(5739):1380-4. PMID:16123302 doi:http://dx.doi.org/10.1126/science.1113401
  9. Ashkar AA, Rosenthal KL. Toll-like receptor 9, CpG DNA and innate immunity. Curr Mol Med. 2002 Sep;2(6):545-56. PMID:12243247
  10. Signorino G, Mohammadi N, Patane F, Buscetta M, Venza M, Venza I, Mancuso G, Midiri A, Alexopoulou L, Teti G, Biondo C, Beninati C. Role of Toll-like receptor 13 in innate immune recognition of group B streptococci. Infect Immun. 2014 Dec;82(12):5013-22. doi: 10.1128/IAI.02282-14. Epub 2014 Sep, 15. PMID:25225249 doi:http://dx.doi.org/10.1128/IAI.02282-14
  11. . PMID:218753640
  12. Stridh L, Mottahedin A, Johansson ME, Valdez RC, Northington F, Wang X, Mallard C. Toll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia. J Neurosci. 2013 Jul 17;33(29):12041-51. doi: 10.1523/JNEUROSCI.0673-13.2013. PMID:23864690 doi:http://dx.doi.org/10.1523/JNEUROSCI.0673-13.2013
  13. Nagashima H, Iwatani S, Cruz M, Jimenez Abreu JA, Uchida T, Mahachai V, Vilaichone RK, Graham DY, Yamaoka Y. Toll-like Receptor 10 in Helicobacter pylori Infection. J Infect Dis. 2015 Nov 15;212(10):1666-76. doi: 10.1093/infdis/jiv270. Epub 2015 , May 14. PMID:25977263 doi:http://dx.doi.org/10.1093/infdis/jiv270



See Also

Additional Literature

  • Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, Segal DM, Davies DR. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science. 2008 Apr 18;320(5874):379-81. PMID:18420935 doi:320/5874/379
  • Bell JK, Askins J, Hall PR, Davies DR, Segal DM. The dsRNA binding site of human Toll-like receptor 3. Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8792-7. Epub 2006 May 23. PMID:16720699 doi:10.1073/pnas.0603245103
  • Nyman T, Stenmark P, Flodin S, Johansson I, Hammarstrom M, Nordlund P. The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J Biol Chem. 2008 May 2;283(18):11861-5. Epub 2008 Mar 10. PMID:18332149 doi:10.1074/jbc.C800001200
  • Chan SL, Low LY, Hsu S, Li S, Liu T, Santelli E, Le Negrate G, Reed JC, Woods VL Jr, Pascual J. Molecular mimicry in innate immunity: crystal structure of a bacterial TIR domain. J Biol Chem. 2009 Aug 7;284(32):21386-92. Epub 2009 Jun 17. PMID:19535337 doi:10.1074/jbc.C109.007591
  • Botos I, Liu L, Wang Y, Segal DM, Davies DR. The toll-like receptor 3:dsRNA signaling complex. Biochim Biophys Acta. 2009 Sep-Oct;1789(9-10):667-74. Epub 2009 Jul 9. PMID:19595807 doi:10.1016/j.bbagrm.2009.06.005
  • Istomin AY, Godzik A. Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs. BMC Immunol. 2009 Sep 3;10:48. PMID:19728889 doi:10.1186/1471-2172-10-48
  • Satake H, Sasaki N. Comparative overview of toll-like receptors in lower animals. Zoolog Sci. 2010 Feb;27(2):154-61. PMID:20141420 doi:10.2108/zsj.27.154
  • Matsushima N, Tanaka T, Enkhbayar P, Mikami T, Taga M, Yamada K, Kuroki Y. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics. 2007 May 21;8:124. PMID:17517123 doi:10.1186/1471-2164-8-124
  • Carpenter S, O'Neill LA. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem J. 2009 Jul 29;422(1):1-10. PMID:19627256 doi:10.1042/BJ20090616
  • Choe J, Kelker MS, Wilson IA. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science. 2005 Jul 22;309(5734):581-5. Epub 2005 Jun 16. PMID:15961631
  • Gong J, Wei T, Zhang N, Jamitzky F, Heckl WM, Rossle SC, Stark RW. TollML: a database of toll-like receptor structural motifs. J Mol Model. 2010 Jul;16(7):1283-9. Epub 2010 Jan 19. PMID:20084417 doi:10.1007/s00894-009-0640-9
  • Jin MS, Lee JO. Structures of the toll-like receptor family and its ligand complexes. Immunity. 2008 Aug 15;29(2):182-91. PMID:18701082 doi:10.1016/j.immuni.2008.07.007

External Resources

Personal tools